Microphone with laptop in the background

Virtual

Back to events
September 26, 2023
6:00 p.m. ET - 7:00 p.m. ET

Deep dive into the hereditary factors that can lead to ovarian cancer.

Event Details

The Ovarian Cancer Canada Speaker Series features experts from across the country discussing a wide range of topics for women living with ovarian cancer and their families and friends.

Join us on Tuesday, September 26 from 6:00 p.m. ET – 7:00 p.m. ET for Early Cancer Detection using Cell-Free DNA Sequencing.

Julia Sobotka, Research Genetic Counsellor and Program Manager of the CHARM consortium, will lead us on a deep dive into the hereditary factors that can lead to ovarian cancer. In this session you will learn about the differences between sporadic and hereditary cancer, and Julia will explore cell-free DNA testing, its benefits and limitations in relation to early cancer detection, and discuss a new clinical trial using cell-free DNA testing for early cancer detection in patients with hereditary cancer syndromes.

This free event will be hosted on Zoom.  A question-and-answer period will follow the presentation. You can submit your questions in advance to speakerseries@ovariancanada.org

Julia Sobotka, Research Genetic Counsellor

Julia Sobotka is a Research Genetic Counsellor at Princess Margaret Hospital, and the Program Manager of the CHARM consortium. CHARM is a pan-Canadian research initiative with a goal to revolutionize the management of patients with hereditary cancer syndromes through the development of a blood test for early cancer detection. Julia has a master’s degree in Molecular Genetics, and a master’s degree in Genetic Counselling, both from the University of Toronto.